To test whether the increased proportion in subG1-phase upon ponatinib treatment is attributed to apoptosis, ponatinib-treated meningioma cells were stained with annexin V/PI and analyzed by flow cytometry (Figure 3A). This evidence concerns the gene ANXA5 and meningioma.